15.63
  Price8.06%   -1.37
(Pre-market: 16.02 +0.39 +2.50%)
Nov-20-21 09:21AM 4 stock picks for the post-pandemic 'nesting' economy from a five-star money managerMarketWatch
Nov-19-21 08:01AM What Especially Stood Out From Invitae's Q3 ResultsThe Motley Fool
Nov-17-21 11:41AM 4 stock picks for the post-pandemic 'nesting' economy from a five-star money managerMarketWatch
Nov-16-21 06:56AM 4 stock picks for the post-pandemic 'nesting' economy from a five-star money managerMarketWatch
06:38AM 3 Beaten-Down Genomics Stocks: Can They Recover?The Motley Fool
Nov-15-21 05:18AM 4 stock picks for the post-pandemic 'nesting' economy from a five-star money managerMarketWatch
11:52AM 4 stock picks for the post-pandemic 'nesting' economy from a five-star money managerMarketWatch
Nov-09-21 08:41AM Why Are Invitae's Shares Plunging Today?Benzinga
08:13AM The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug DataBenzinga
Nov-09-21 06:13AM 3 Stocks That Could Soar 46% or More, According to Wall StreetThe Motley Fool
03:30AM Invitae (NVTA) Q3 2021 Earnings Call TranscriptThe Motley Fool
Nov-08-21 08:24AM The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And MoreBenzinga
Oct-03-21 06:14AM 3 Sinking Stocks Cathie Wood Keeps Buying AnywayThe Motley Fool
Sep-21-21 09:18AM PacBio (PACB) Closes Omniome Buyout, Forays Into San DiegoZacks Investment Research
Sep-20-21 06:21AM Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps BuyingThe Motley Fool
Sep-18-21 09:15AM A Second Week of Declines as September ContinuesZacks Investment Research
Sep-09-21 07:52AM Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just BoughtThe Motley Fool
Sep-07-21 08:08AM Wall Street Breakfast: El Salvador Adopts Bitcoin (Podcast)Seeking Alpha
06:36AM Wall Street Breakfast: Reddit Targets BitcoinSeeking Alpha
Sep-05-21 08:01AM Wall Street Breakfast: The Week Ahead (Podcast)Seeking Alpha
07:07AM Wall Street Breakfast: The Week AheadSeeking Alpha
Sep-04-21 10:15AM Stocks To Watch: GameStop, Affirm, Lululemon And Sports Betting PlaysSeeking Alpha
Aug-17-21 08:28AM The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology BusinessBenzinga
Aug-14-21 01:33AM Making Sense Of The Possible Merger Between Exact Sciences And InvitaeSeeking Alpha
Aug-06-21 06:02AM Why Did Invitae Stock Fall 17% in July?The Motley Fool
Aug-05-21 09:15AM S&P Off Record High, Dow Down 300 Points as Jobs Data BeginsZacks Investment Research
Aug-04-21 12:55PM Why Invitae Stock Is Climbing TodayThe Motley Fool
09:33AM Invitae Stock Jumps As Higher Test Volume More Than Doubles Q2 Topline, Raises FY21 Sales OutlookBenzinga
Aug-04-21 09:01AM Invitae (NVTA) Q2 2021 Earnings Call TranscriptThe Motley Fool
07:52AM The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On EarningsBenzinga
Aug-04-21 06:45AM $5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 YearsThe Motley Fool
Aug-03-21 05:39AM 14 Stocks Moving In Tuesday's After-Hours SessionBenzinga
07:55AM The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics BusinessBenzinga
Aug-01-21 10:13AM The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOsBenzinga
Jul-30-21 06:20AM Bear of the Day: NeoGenomics (NEO)Zacks Investment Research
Jul-27-21 03:03AM Will Invitae (NVTA) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research
Jul-23-21 07:02AM PacBio (PACB) Enhances Sequencing Platform Via Latest BuyoutZacks Investment Research
Jul-19-21 05:20AM Bull of the Day: Exact Sciences (EXAS)Investing.com
Jul-16-21 07:01AM Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This WeekThe Motley Fool
Jul-15-21 12:14PM Tech Bubble 2.0 + Inflation Tsunami: How to Play Them NowZacks Investment Research
09:15AM Stocks Mixed Amid Earnings Reports, Powell and PPIZacks Investment Research
Jul-13-21 06:35AM 3 Things About Invitae That Smart Investors Should KnowThe Motley Fool
Jul-10-21 06:12AM Where Will ARK Genomic Revolution ETF Be in 5 Years?The Motley Fool
Jun-30-21 05:50AM Invitae (NVTA) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research
Jun-24-21 05:50AM Invitae (NVTA) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research
Jun-18-21 05:50AM Invitae (NVTA) Gains As Market Dips: What You Should KnowZacks Investment Research
Jun-15-21 10:24AM Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021Benzinga
Jun-11-21 05:50AM Invitae (NVTA) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research
Jun-08-21 03:46AM Why Invitae Was Down 17.5% in MayThe Motley Fool
Jun-07-21 07:11AM What's the Best Way to Invest in Genetics Stocks?The Motley Fool
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; proactive health and wellness screening; and preimplantation embryo testing and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It also operates Patient Insights Networks, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform that is used for the collection, analysis, and management of patient family history information. Invitae Corporation serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Cap:    |  Volume (24h):